Galectin Therapeutics Inc...

NASDAQ: GALT · Real-Time Price · USD
3.57
-0.19 (-5.05%)
At close: Aug 15, 2025, 3:59 PM
3.55
-0.56%
After-hours: Aug 15, 2025, 06:50 PM EDT

Galectin Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
15.12M 25.66M 18.59M 39.65M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
243K 437K 733K 7K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.13M 2.05M 1.96M 2.17M
Total Current Assets
17.25M 27.71M 20.55M 41.82M
Property-Plant & Equipment
n/a 53K n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
243K 490K 733K 7K
Total Assets
17.5M 28.2M 21.29M 41.83M
Account Payables
5.66M 6.43M 3.89M 1.8M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
21.12M n/a n/a n/a
Other Current Liabilities
1.89M 8.07M 8.11M 6.49M
Total Current Liabilities
35.41M 15.68M 13.01M 9.03M
Long-Term Debt
85.11M 71.74M 39.83M 29.05M
Other Long-Term Liabilities
47K 1M 573K 1.13M
Total Long-Term Liabilities
85.16M 72.77M 40.47M 30.18M
Total Liabilities
120.56M 88.44M 53.48M 39.21M
Total Debt
106.25M 71.81M 39.87M 29.06M
Common Stock
62K 61K 59K 59K
Retained Earnings
-401.57M -354.37M -309.57M -270.69M
Comprehensive Income
n/a 0.00 n/a 0.00
Shareholders Equity
-103.07M -60.24M -32.19M 2.62M
Total Investments
n/a n/a n/a n/a